138 related articles for article (PubMed ID: 1721385)
1. Changes in renal function after liver transplantation under FK 506.
McCauley J; Fung JJ; Todo S; Jain A; Deballi P; Starzl TE
Transplant Proc; 1991 Dec; 23(6):3143-5. PubMed ID: 1721385
[No Abstract] [Full Text] [Related]
2. A comparison of renal function in cyclosporine- and FK-506-treated patients after primary orthotopic liver transplantation.
McDiarmid SV; Colonna JO; Shaked A; Ament ME; Busuttil RW
Transplantation; 1993 Oct; 56(4):847-53. PubMed ID: 7692636
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the renal effects (ERPF, GFR, and FF) of FK 506 and cyclosporine in patients with liver transplantation.
Tauxe WN; Mochizuki T; McCauley J; Starzl TE; Jain A; Charron M
Transplant Proc; 1991 Dec; 23(6):3146-7. PubMed ID: 1721386
[TBL] [Abstract][Full Text] [Related]
4. Comparison of short and long-term renal function in liver transplant patients receiving cyclosporin or FK 506.
Mor E; Patel T; Glabman S; Sheiner P; Emre S; Guy S; Schwartz M; Miller C
Transpl Int; 1994; 7 Suppl 1():S77-80. PubMed ID: 11271340
[TBL] [Abstract][Full Text] [Related]
5. Early posttransplantation renal hemodynamics in FK 506-treated kidney recipients with or without prior induction therapy.
Rostaing L; Tran-Van T; Cisterne JM; Tack I; Durand D; Ader JL
Transplant Proc; 1998 Jun; 30(4):1279-81. PubMed ID: 9636519
[No Abstract] [Full Text] [Related]
6. Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.
Porayko MK; Textor SC; Krom RA; Hay JE; Gores GJ; Wahlstrom HE; Sanchez-Urdazpal L; Richards T; Crotty P; Beaver S
Transplant Proc; 1993 Feb; 25(1 Pt 1):665-8. PubMed ID: 7679835
[No Abstract] [Full Text] [Related]
7. Renal function after conversion from cyclosporine to FK 506 in liver transplant patients.
McCauley J; Fung JJ; Brown H; Deballi P; Jain A; Todo S; Starzl TE
Transplant Proc; 1991 Dec; 23(6):3148-9. PubMed ID: 1721387
[No Abstract] [Full Text] [Related]
8. Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group.
Porayko MK; Gonwa TA; Klintmalm GB; Wiesner RH
Transplant Proc; 1995 Feb; 27(1):1114-6. PubMed ID: 7533358
[No Abstract] [Full Text] [Related]
9. Influence of early FK 506 trough levels on glomerular hemodynamics at 3 months in kidney transplant recipients.
Rostaing L; Tran-Van T; Cisterne JM; Tack I; Durand D; Ader JL
Transplant Proc; 1998 Jun; 30(4):1282-4. PubMed ID: 9636520
[No Abstract] [Full Text] [Related]
10. Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation.
Porayko MK; Textor SC; Krom RA; Hay JE; Gores GJ; Richards TM; Crotty PH; Beaver SJ; Steers JL; Wiesner RH
Mayo Clin Proc; 1994 Feb; 69(2):105-11. PubMed ID: 7508536
[TBL] [Abstract][Full Text] [Related]
11. Chronic nephrotoxicity of FK 506 after liver transplantation.
Bäckman L; Nicar M; Levy M; Distant D; Eisenstein C; Renard T; Goldstein R; Husberg B; Gonwa T; Klintmalm G
Transplant Proc; 1994 Jun; 26(3):1803. PubMed ID: 7518159
[No Abstract] [Full Text] [Related]
12. Renal function estimation in cirrhosis.
Turgut F; Akcay A
Am J Transplant; 2009 Aug; 9(8):1968. PubMed ID: 19519814
[No Abstract] [Full Text] [Related]
13. Association of elevated FK 506 plasma levels with nephrotoxicity in liver-grafted patients.
Winkler M; Jost U; Ringe B; Gubernatis G; Wonigeit K; Pichlmayr R
Transplant Proc; 1991 Dec; 23(6):3153-5. PubMed ID: 1721389
[No Abstract] [Full Text] [Related]
14. Role of endothelin in FK 506-induced renal hypoperfusion in rats.
Kumano K; Chen J; He M; Endo T; Masaki Y
Transplant Proc; 1995 Feb; 27(1):550-3. PubMed ID: 7533423
[No Abstract] [Full Text] [Related]
15. Renal function in liver transplant patients receiving FK506 or cyclosporin A immunosuppressive therapy.
Frei U; Wagner K
Transplant Proc; 1994 Dec; 26(6):3270-1. PubMed ID: 7527963
[No Abstract] [Full Text] [Related]
16. Changes in renal function in long-term survivors of liver transplantation: a comparison between cyclosporine microemulsion and tacrolimus therapy.
Charco R; Cantarell C; Castells LI; Bilbao I; Hidalgo E; Capdevila L; Margarit C
Transplant Proc; 2002 Aug; 34(5):1548-9. PubMed ID: 12176478
[No Abstract] [Full Text] [Related]
17. Prediction of chronic kidney disease progression used by calcineurin inhibitor concentration and estimated glomerular filtration rate early after liver transplantation.
Ye L; Zhang Y; Tang H; Yao J; Wang G; Yang Y; Chen G
Niger J Clin Pract; 2020 Oct; 23(10):1387-1394. PubMed ID: 33047695
[TBL] [Abstract][Full Text] [Related]
18. Plasma level-guided low-dose FK 506 therapy in patients with early liver dysfunction after liver transplantation.
Winkler M; Ringe B; Jost U; Gubernatis G; Pichlmayr R
Transplant Proc; 1993 Aug; 25(4):2688-90. PubMed ID: 7689277
[No Abstract] [Full Text] [Related]
19. Whole blood and plasma levels of FK 506 after liver transplantation: correlation with toxicity.
Bäckman L; Nicar M; Levy M; Distant D; Eisenstein C; Renard T; Goldstein R; Husberg B; Gonwa T; Klintmalm G
Transplant Proc; 1994 Jun; 26(3):1804. PubMed ID: 7518160
[No Abstract] [Full Text] [Related]
20. Functional and structural characteristics of experimental FK 506 nephrotoxicity.
Andoh TF; Burdmann EA; Lindsley J; Houghton DC; Bennett WM
Clin Exp Pharmacol Physiol; 1995 Sep; 22(9):646-54. PubMed ID: 8542679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
